AIM IMMUNOTECH INC (AIM)
US00901B1052 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 5.44M | 27.05M | 32.09M | 38.50M | 1.47M | |||
| Marketable Securities | 7.63M | 7.14M | 16.18M | 501.00K | 7.31M | |||
| Receivables | 1.18M | 1.68M | 1.64M | 1.12M | 820.00K | |||
| Inventories | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 302.00K | 455.00K | 304.00K | 184.00K | 848.00K | |||
| Total Current Assets | 14.56M | 36.32M | 50.21M | 40.31M | 10.45M | |||
| Non-Current Assets | ||||||||
| PPE Net | 824.00K | 1.02M | 4.20M | 6.65M | 7.27M | |||
| Investments And Advances | N/A | N/A | 0.00 | 15.38M | N/A | |||
| Intangibles | 2.31M | 1.94M | 1.97M | 1.50M | 1.15M | |||
| Other Non-Current Assets | 1.69M | 1.20M | 1.32M | 748.00K | 1.89M | |||
| Total Non-Current Assets | 4.83M | 4.17M | 7.49M | 24.27M | 10.31M | |||
| TOTAL ASSETS | 19.38M | 40.49M | 57.70M | 64.58M | 20.75M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 230.00K | 214.00K | |||
| Accrued Expenses | 2.21M | 984.00K | 475.00K | 489.00K | 441.00K | |||
| Accounts Payable | 6.44M | 377.00K | 198.00K | 383.00K | 472.00K | |||
| Total Current Liabilities | 8.65M | 1.36M | 673.00K | 1.10M | 1.13M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 1.88M | 6.01M | |||
| Other Non-Current Liabilities | 495.00K | 659.00K | 147.00K | 312.00K | 171.00K | |||
| Total Non-Current Liabilities | 495.00K | 659.00K | 147.00K | 2.19M | 6.18M | |||
| TOTAL LIABILITIES | 9.15M | 2.02M | 820.00K | 3.29M | 7.31M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -409.51M | -380.55M | -361.10M | -341.97M | -327.57M | |||
| Additional Paid In Capital | 419.00M | 418.27M | 417.22M | 402.54M | 340.23M | |||
| Common Shares | 738.00K | 744.00K | 763.00K | 774.00K | 788.00K | |||
| Shares Outstanding | 49.10M | 48.08M | 47.99M | 42.15M | 10.39M | |||
| Tangible Book Value per Share | 0.15 | 0.75 | 1.13 | 1.40 | 1.11 | |||
| Total Shareholders' Equity | 10.23M | 38.47M | 56.88M | 61.29M | 13.44M | |||
| TOTAL LIABILITIES AND EQUITY | 19.38M | 40.49M | 57.70M | 64.58M | 20.75M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.03 | 0.45 | |||
| Current Ratio | 1.68 | 26.69 | 74.61 | 36.58 | 9.27 | |||
| Return On Assets (ROA) | -149.44% | -48.03% | -33.15% | -22.30% | -45.31% | |||
| Return On Equity (ROE) | -283.00% | -50.55% | -33.63% | -23.49% | -69.96% | |||
All data in USD